• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Edges Higher; Virco Manufacturing Shares Surge After Q2 Results

    9/11/23 12:03:13 PM ET
    $AVTA
    $CRNX
    $GRNT
    $NBY
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AVTA alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday.

    The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P 500, also rose, gaining, 0.52% to 4,480.87.

    Check This Out: Lattice Semiconductor, Navitas Semiconductor And 2 Other Stocks Insiders Are Selling

     

    Leading and Lagging Sectors

    Consumer discretionary shares jumped by 1.8% on Monday.

    In trading on Monday, information technology shares fell by 0.2%.

     

    Top Headline

    Virco Mfg. Corporation (NASDAQ:VIRC) shares jumped around 12% on Monday after the company reported better-than-expected second-quarter earnings.

    Virco Mfg posted quarterly earnings of 95 cents per share, beating market estimates of 64 cents per share. The company’s quarterly sales came in at $107.32 million versus expectations of $95.22 million.

     

    Equities Trading UP

    NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares shot up 32% to $0.8199 after the company granted Biostem Technologies the right to commercialize amniotic tissue allograft, which is intended for use as a protective covering during the repair of ocular surfaces.

    Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) got a boost, shooting 73% to $27.58 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.

    Avantax, Inc. (NASDAQ:AVTA) shares were also up, gaining 28% to $25.52 as the company agreed to be acquired by Cetera Holdings for $26 per share in cash.

     

    Equities Trading DOWN

    SigmaTron International, Inc. (NASDAQ:SGMA) shares dropped 47% to $3.9791 after the company released first-quarter earnings.

    Shares of Tenon Medical, Inc. (NASDAQ:TNON) were down 36% to $0.1601 after the company announced proposed public offering of common stock.

    Granite Ridge Resources, Inc. (NYSE:GRNT) was down, falling 11% to $6.66. Granite Ridge Resources launched a secondary public offering of 7.1 million shares by selling stockholders.

    Also Check This Out: This Analyst With 87% Accuracy Rate Sees More Than 20% Upside In RH - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

     

    Commodities

    In commodity news, oil traded up 0.1% to $87.53 while gold traded up 0.3% at $1,948.40.

    Silver traded up 0.8% to $23.36 on Monday while copper rose 2.3% to $3.8005.

     

    Euro zone

    European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.18% London’s FTSE 100 fell 0.08% while Spain’s IBEX 35 Index rose 0.49% The German DAX rose 0.28% French CAC 40 rose 0.42%, while Italy’s FTSE MIB Index rose 0.76%.

    Industrial production in Italy fell 0.7% from a month ago in July versus a 0.5% growth in the prior month.

     

    Asia Pacific Markets

    Asian markets closed mixed on Monday, with Japan’s Nikkei 225 falling 0.43%, Hong Kong’s Hang Seng Index fell 0.58% and China’s Shanghai Composite Index gaining 0.84%. India’s S&P BSE Sensex, meanwhile, rose 0.5%.

    China's consumer prices increased by 0.1% year-over-year in August compared to market views of a 0.2% gain, while producer prices fell 3.0% year-over-year in August following a 4.4% decline a month ago. China's vehicle sales jumped by 8.4% year-over-year to 2.582 million units in August versus a 1.4% fall in the prior month, while total social financing increased to CNY 3.12 trillion in August from CNY 0.53 trillion a month ago. Japan's machine tool orders declined 17.6% year-over-year to JPY 114,746 million in August.

     

    Economics

    There were no major US economic releases Monday.

    Now Read This: Top 5 Materials Stocks That Could Blast Off This Month

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,296,300 cases with around 1,174,580 deaths. India confirmed a total of at least 44,997,710 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,108,160 cases of COVID-19 worldwide with more than 6,914,370 deaths.

    Get the next $AVTA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVTA
    $CRNX
    $GRNT
    $NBY

    CompanyDatePrice TargetRatingAnalyst
    Crinetics Pharmaceuticals Inc.
    $CRNX
    1/12/2026$67.00Neutral → Buy
    Goldman
    Crinetics Pharmaceuticals Inc.
    $CRNX
    7/10/2025$36.00Neutral
    Goldman
    Crinetics Pharmaceuticals Inc.
    $CRNX
    3/25/2025$60.00Buy
    Stifel
    Granite Ridge Resources Inc.
    $GRNT
    2/21/2025Overweight → Equal Weight
    CapitalOne
    Crinetics Pharmaceuticals Inc.
    $CRNX
    2/11/2025Buy
    TD Cowen
    Crinetics Pharmaceuticals Inc.
    $CRNX
    2/4/2025Peer Perform
    Wolfe Research
    Crinetics Pharmaceuticals Inc.
    $CRNX
    1/22/2025$55.00Hold → Buy
    Jefferies
    Granite Ridge Resources Inc.
    $GRNT
    6/14/2024$7.00Neutral
    BofA Securities
    More analyst ratings

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Virtue Robert A bought $15,800 worth of Common Stock $.01 par value (2,500 units at $6.32), increasing direct ownership by 0.51% to 495,824 units (SEC Form 4)

    4 - VIRCO MFG CORPORATION (0000751365) (Issuer)

    1/13/26 5:29:20 PM ET
    $VIRC
    Industrial Specialties
    Consumer Discretionary

    Director Richardson Bradley C bought $13,009 worth of Common Stock $.01 par value (2,000 units at $6.50), increasing direct ownership by 6% to 37,754 units (SEC Form 4)

    4 - VIRCO MFG CORPORATION (0000751365) (Issuer)

    1/7/26 4:19:05 PM ET
    $VIRC
    Industrial Specialties
    Consumer Discretionary

    Director Miller Matthew Reade bought $3,324 worth of shares (648 units at $5.13), increasing direct ownership by 0.05% to 1,298,166 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    12/17/25 11:44:02 AM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Weimer Kimberly covered exercise/tax liability with 2,642 shares, decreasing direct ownership by 3% to 97,914 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    3/9/26 5:45:08 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    President and CEO Farquharson Tyler was granted 47,656 shares, increasing direct ownership by 17% to 322,243 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    3/6/26 2:27:02 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Chief Financial Officer Kettler Ronald Kyle was granted 17,110 shares, increasing direct ownership by 17% to 115,276 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    3/6/26 2:24:45 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Crinetics Pharmaceuticals upgraded by Goldman with a new price target

    Goldman upgraded Crinetics Pharmaceuticals from Neutral to Buy and set a new price target of $67.00

    1/12/26 7:47:46 AM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Goldman initiated coverage on Crinetics Pharmaceuticals with a new price target

    Goldman initiated coverage of Crinetics Pharmaceuticals with a rating of Neutral and set a new price target of $36.00

    7/10/25 8:53:33 AM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Stifel initiated coverage on Crinetics Pharmaceuticals with a new price target

    Stifel initiated coverage of Crinetics Pharmaceuticals with a rating of Buy and set a new price target of $60.00

    3/25/25 8:26:55 AM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVTA
    $CRNX
    $GRNT
    $NBY
    SEC Filings

    View All

    Virco Manufacturing Corporation filed SEC Form 8-K: Regulation FD Disclosure

    8-K - VIRCO MFG CORPORATION (0000751365) (Filer)

    3/9/26 2:01:15 PM ET
    $VIRC
    Industrial Specialties
    Consumer Discretionary

    SEC Form 10-K filed by Granite Ridge Resources Inc.

    10-K - Granite Ridge Resources, Inc. (0001928446) (Filer)

    3/5/26 8:26:33 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Granite Ridge Resources Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Granite Ridge Resources, Inc. (0001928446) (Filer)

    3/5/26 4:28:19 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Granite Ridge Resources, Inc. Reports Fourth Quarter and Full-Year 2025 Results and Provides Outlook for 2026

    Granite Ridge Resources, Inc. (NYSE:GRNT) ("Granite Ridge" or the "Company") today reported financial and operating results for the fourth quarter and full-year 2025 and provided initial guidance for 2026. Fourth Quarter 2025 Highlights Increased total production by 27% to 35,120 Boe/day (49% oil) including a 17% increase in oil production Reported net loss of $25.1 million, or $(0.19) per share, and Adjusted Net Income (non-GAAP) of $1.5 million, or $0.01 Adjusted Earnings Per Diluted Share (non-GAAP) Generated Adjusted EBITDAX (non-GAAP) of $69.5 million Invested $127.5 million of capital, placing online 67 gross (10.50 net) wells Declared a dividend of $0.11 per share

    3/5/26 4:19:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    PALSONIFY™ (Paltusotine) Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December       Operationally Seamless Phase 2/3 Study of Atumelnant for the Treatment of ACTH-Dependent Cushing's Syndrome to Initiate in the First Half of 2026       Multiple Clinical Trials Initiated for Early- and Late-Stage Candidates               Management Hosting Conference Call at 4:30 p.m. ET Today         SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-relate

    2/26/26 4:05:00 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Granite Ridge Resources Declares Quarterly Cash Dividend and Schedules Fourth Quarter 2025 Earnings Conference Call

    Granite Ridge Resources, Inc. ("Granite Ridge" or the "Company") (NYSE:GRNT) today announced that its Board of Directors declared a regular quarterly dividend of $0.11 per share payable on March 13, 2026, to shareholders of record as of February 27, 2026. Future declarations of dividends are subject to approval by the Board of Directors. Fourth Quarter 2025 Earnings Conference Call Granite Ridge will report its financial and operating results for the fourth quarter of 2025 on Thursday, March 5, 2026, after the close of trading on the New York Stock Exchange. The Company will host a webcast and conference call on Friday, March 6, 2026, at 10:00 a.m. central time to discuss its fourth qua

    2/13/26 4:08:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Financials

    Live finance-specific insights

    View All

    Granite Ridge Resources, Inc. Reports Fourth Quarter and Full-Year 2025 Results and Provides Outlook for 2026

    Granite Ridge Resources, Inc. (NYSE:GRNT) ("Granite Ridge" or the "Company") today reported financial and operating results for the fourth quarter and full-year 2025 and provided initial guidance for 2026. Fourth Quarter 2025 Highlights Increased total production by 27% to 35,120 Boe/day (49% oil) including a 17% increase in oil production Reported net loss of $25.1 million, or $(0.19) per share, and Adjusted Net Income (non-GAAP) of $1.5 million, or $0.01 Adjusted Earnings Per Diluted Share (non-GAAP) Generated Adjusted EBITDAX (non-GAAP) of $69.5 million Invested $127.5 million of capital, placing online 67 gross (10.50 net) wells Declared a dividend of $0.11 per share

    3/5/26 4:19:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Granite Ridge Resources Declares Quarterly Cash Dividend and Schedules Fourth Quarter 2025 Earnings Conference Call

    Granite Ridge Resources, Inc. ("Granite Ridge" or the "Company") (NYSE:GRNT) today announced that its Board of Directors declared a regular quarterly dividend of $0.11 per share payable on March 13, 2026, to shareholders of record as of February 27, 2026. Future declarations of dividends are subject to approval by the Board of Directors. Fourth Quarter 2025 Earnings Conference Call Granite Ridge will report its financial and operating results for the fourth quarter of 2025 on Thursday, March 5, 2026, after the close of trading on the New York Stock Exchange. The Company will host a webcast and conference call on Friday, March 6, 2026, at 10:00 a.m. central time to discuss its fourth qua

    2/13/26 4:08:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

    SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call & Webcast Thursday, February 26 at 4:30 p.m. ET Domestic: 1 833-470-1428International: 1 646-844-6383Access Code: 027322    Webcast: Participants can use the dial-in numbers above OR access the live webcast via a direct link (HERE) or by visiting the Events section of the Crinetics website. To ensure a timely connection,

    1/26/26 5:00:00 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Leadership Updates

    Live Leadership Updates

    View All

    Granite Ridge Resources, Inc. Appoints Kyle Kettler as Chief Financial Officer

    Granite Ridge Resources, Inc. ("Granite Ridge" or the "Company") (NYSE:GRNT) today announced the appointment of Kyle Kettler as Chief Financial Officer, effective February 9, 2026. Mr. Kettler brings over 25 years of experience across energy finance and capital markets, with deep expertise in financing oil and gas companies in the public and private markets. He will be responsible for overseeing Granite Ridge's financial operations and will play a significant leadership role in guiding the Company's financial and business strategy to support the Company's long-term growth objectives while enhancing shareholder value. "I am thrilled to welcome Kyle to Granite Ridge, as this appointment u

    2/5/26 4:08:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting

    EMERYVILLE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) (the "Company") previously announced a one-time special cash dividend of $0.80 per share for the Company's common stock. The special cash dividend will be payable on September 29, 2025 to stockholders of record as of the close of business on September 15, 2025. Because the payment of the special dividend represents more than 25% of the price of the Company's common stock, NYSE American advised the Company that its common stock will trade with "due bills" representing an assignment of the right to receive the special dividend from the record date of September 15, 2025 through the close of tradi

    9/18/25 4:30:00 PM ET
    $NBY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Granite Ridge Resources, Inc. Announces CEO Transition

    Granite Ridge Resources, Inc. ("Granite Ridge" or the "Company") (NYSE:GRNT) today announced that Luke Brandenberg has stepped down from his role as President and Chief Executive Officer, effective June 11, 2025. The Company's Board has promoted Tyler Farquharson, the Company's Chief Financial Officer, to President and Chief Executive Officer, and Kim Weimer, the Company's Chief Accounting Officer, to Interim Chief Financial Officer and Chief Accounting Officer, each effective June 12, 2025. The Board is actively seeking a permanent Chief Financial Officer and has retained a nationally recognized executive search firm to assist in the process. Granite Ridge reaffirms its operational and f

    6/12/25 8:55:00 AM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AVTA
    $CRNX
    $GRNT
    $NBY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 7:55:29 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 5:46:54 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Crinetics Pharmaceuticals Inc.

    SC 13G - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 1:22:38 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care